An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.
Tysabri related Progressive Multifocal Leukoencephalopathy: biological plausibility explained: A Detailed Overview — detailed background and analysis.
Reference: European Medicines Agency (EMA)
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: National Institutes of Health (NIH)
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: MedlinePlus — Trusted Health Information
Authoritative source for clinical, regulatory, and public-health background reading.